Pirfenidone ameliorates concanavalin A-induced hepatitis in mice via modulation of reactive oxygen species/nuclear factor kappa B signalling pathways

Angelica sinensis polysaccharide attenuates concanavalin A-induced liver injury in mice

(2016) Kaiping Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Antiadhesive and anti-inflammatory effects of pirfenidone in postoperative intra-abdominal adhesion in an experimental rat model

(2016) Zulfu Bayhan et al.   JOURNAL OF SURGICAL RESEARCH

High Quality Tissue Miniarray Technique Using a Conventional TV/Radio Telescopic Antenna

(2015) Mohamed A. Elkablawy et al.   Asian Pacific Journal of Cancer Prevention

Emodin Protects Against Concanavalin A-Induced Hepatitis in Mice Through Inhibiting Activation of the p38 MAPK-NF-κB Signaling Pathway

(2015) Jihua Xue et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Paeoniflorin protects against concanavalin A-induced hepatitis in mice

(2015) Mingsheng Chen et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Protective effects of hesperidin on concanavalin A-induced hepatic injury in mice

(2014) Gang Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis

(2014) Minoru Inomata et al.   RESPIRATORY RESEARCH

Protective effects of BML-111 against acetaminophen-induced acute liver injury in mice

(2013) Dina S. El-Agamy et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Autoimmune hepatitis

(2013) Michael A Heneghan et al.   LANCET

Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in Mice

(2013) Yingqun Zhou et al.   MEDIATORS OF INFLAMMATION

Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice

(2013) Xiaomei Xu et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

The innate immune response during liver inflammation and metabolic disease

(2013) Veerle Bieghs et al.   TRENDS IN IMMUNOLOGY

NCPP treatment alleviates ConA-induced hepatitis via reducing CD4+T activation and NO production

(2012) Chenghu Liu et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Immune mechanisms of Concanavalin A model of autoimmune hepatitis

(2012) Hai-Xia Wang   WORLD JOURNAL OF GASTROENTEROLOGY

Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis

(2011) Jose Navarro-Partida et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inhibition of Immune-Mediated Concanavalin A-Induced Liver Damage by Free-Radical Scavengers

(2009) Haim Shirin et al.   DIGESTIVE DISEASES AND SCIENCES

Pirfenidone Inhibits T-Cell Activation, Proliferation, Cytokine and Chemokine Production, and Host Alloresponses

(2009) Gary A. Visner et al.   TRANSPLANTATION

Effects of Kupffer cell-depletion on Concanavalin A-induced hepatitis

(2008) Masayo Hatano et al.   CELLULAR IMMUNOLOGY

Potent antioxidant role of Pirfenidone in experimental cirrhosis

(2008) Adriana Salazar-Montes et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis

(2008) Hisashi Oku et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-κB activation

(2008) Dechun Feng et al.   IMMUNOLOGY LETTERS

Protective effects of pirfenidone on D-galactosamine and lipopolysaccharide-induced acute hepatotoxicity in rats

(2008) F. Wang et al.   INFLAMMATION RESEARCH

Sodium Tanshinone IIA Sulfonate Protects Mice From ConA-Induced Hepatitis via Inhibiting NF-κB and IFN-γ/STAT1 Pathways

(2008) Yan Xu et al.   JOURNAL OF CLINICAL IMMUNOLOGY